Abstract:The binding of drugs to plasma proteins determines its fate within the physiological system, hence profound understanding of its interaction within the bloodstream is important to understand its pharmacodynamics and pharmacokinetics and thereby its therapeutic potential. In this regard, our work delineates the mechanism of interaction of Selumetinib (SEL), a potent anti‐cancer drug showing excellent effect against multiple solid tumors, with plasma protein bovine serum albumin (BSA), using methods such as absorption, steady‐state fluorescence, time‐resolved, fluorescence resonance energy transfer, Fourier transform infrared spectra (FTIR), circular dichroism (CD), synchronous and 3D‐fluorescence, salt fluorescence, molecular docking and molecular dynamic simulations. The BSA fluorescence intensity was quenched with increasing concentration of SEL which indicates interactions of SEL with BSA. Stern–Volmer quenching analysis and lifetime studies indicate the involvement of dynamic quenching. However, some contributions from the static quenching mechanism could not be ruled out unambiguously. The association constant was found to be 5.34 × 105 M−1 and it has a single binding site. The Förster distance (r) indicated probable energy transmission between the BSA and SEL. The positive entropy changes and enthalpy change indicate that the main interacting forces are hydrophobic forces, also evidenced by the results of molecular modeling studies. Conformation change in protein framework was revealed from FTIR, synchronous and 3D fluorescence and CD studies. Competitive binding experiments as well as docking studies suggest that SEL attaches itself to site I (subdomain IIA) of BSA where warfarin binds. Molecular dynamic simulations indicate the stability of the SEL–BSA complex. The association energy between BSA and SEL is affected in the presence of different metals differently.

In vitro study on the binding of gemcitabine to bovine serum albumin.

Experimental and computational investigation on the binding of anticancer drug gemcitabine with bovine serum albumin

Spectroscopic and Molecular Docking Studies of Binding Interaction of Gefitinib, Lapatinib and Sunitinib with Bovine Serum Albumin (BSA).

Probing the Binding Reaction of Cytarabine to Human Serum Albumin Using Multispectroscopic Techniques with the Aid of Molecular Docking

Binding of several anti-tumor drugs to bovine serum albumin: Fluorescence study

Binding Interaction of Sorafenib with Bovine Serum Albumin: Spectroscopic Methodologies and Molecular Docking.

Fluorescence Study of A Gemini Surfactant Glycol bis-N-tetradecyl Nicotinate Bibromide with Bovine Serum Albumin

Characterization of Interaction of Calf Thymus DNA with Gefitinib: Spectroscopic Methods and Molecular Docking

Investigation On The Site-Selective Binding Of Bovine Serum Albumin By Erlotinib Hydrochloride

In vitro study on binding interaction of quinapril with bovine serum albumin (BSA) using multi-spectroscopic and molecular docking methods.

Binding of Teicoplanin and Vancomycin to Bovine Serum Albumin in Vitro: a Multispectroscopic Approach and Molecular Modeling

Binding Interaction of Atorvastatin with Bovine Serum Albumin: Spectroscopic Methods and Molecular Docking.

Thermochemistry Study on Interaction Between Anti-tumor Drug Tegafur and Bovine Serum Albumin

Fluorescence spectroscopic studies on the interaction of Gemini surfactant 14-6-14 with bovine serum albumin.

Binding Interaction of Gatifloxacin with Bovine Serum Albumin

el genistein amino acid derivatives and investigation on their interactions with bovine serum albumin by spectroscopy and molecular docking †

Multispectroscopic, electrochemical and molecular docking approaches on binding comparison of camptothecin, 10-hydroxycamptothecin to bovine serum albumin

Exploring the interaction of a potent anti‐cancer drug Selumetinib with bovine serum albumin: Spectral and computational attributes

Preparation of albumin nanospheres loaded with gemcitabine and their cytotoxicity against BXPC-3 cells in vitro

Exploring the binding mechanism of Ginsenoside Rd to Bovine Serum Albumin: Experimental studies and computational simulations

Spectroscopic Studies on the Interaction Between an Anticancer Drug Ampelopsin and Bovine Serum Albumin